Complement system disturbances in myelodysplastic syndromes;Alteraciones del sistema complemento en síndromes mielodisplásicos

Sangre

Volumn 43, Issue 3, 1998, Pages 210-212

  Blanco, Rinaldo Villaescusa ^a   Arce, Ada A ^a   Santos, Rosa M ^a   Fernández, Norma ^a  

^a INSTITUTO DE HEMATOLOGÍA E INMUNOLOGÍA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; FEMALE; HEMOLYSIS; HUMAN; IMMUNOLOGY; INFECTION; MALE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROME; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT FACTOR B; COMPLEMENT SYSTEM PROTEINS; FEMALE; HEMOLYSIS; HUMANS; INFECTION; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 2442623420     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bennett GM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndrome. Br J Haematol 1982; 51: 189-199.
2. Williamson PJ, Oscier DG, Mufti GJ, Hambin TJ. Pyogenic abscesses in myelodysplastic syndromes. Br Med J 1989; 299: 375-376.
3. Reizenstein P. Minimal diagnostic criteria for the myelodysplastic syndromes in clinical practice. Leuk Res 1992; 16: 3-11.
4. Hamblin TJ. Immunologic abnormalities in myelodysplastic syndromes. Hematol Oncol 1992; 6: 571-586
5. Kerndrup G, Meyer K, Ellegard J, Hokland P. Natural killer cell activity and antibody dependent cellular cytotoxicity in primary pre-leukemic syndrome. Leuk Res 1984; 8: 239-247.
6. Colombat PH. Immunologic indices in myelodysplastic syndromes. Cancer 1988; 61: 1075-1081.
7. Savige JA, Chang L, Smith CL, Duggan JC. Myelodysplastic syndromes, vasculitis and antineutrophil cytoplasm antibodies. Leuk Lymphoma 1993; 9: 49-54.
8. Warren AJ, Hegde UM, Nathwani A, Reill IA. Systemic vasculitis and myelodysplasia. Br J Haematol 1990; 75: 627-629
9. nd ed Illinois. Thomas Publisher 1967; 133-240.
10. Platts-Mills TAE, Ishizaka K. Activation of the alternate pathway of human complement by rabbit cells. J Immunol 1974; 113: 348-358.
11. Aguado MT, Celada A, Lambert PH Medida de la función de la vía alterna del complemento. Actividad hemolítica y solubilización de inmunocomplejos.. Inmunología 1983, 2. 63-70
12. th Colloq Bruges, Oxford: Pergamon Press 1964; 370-373.
13. Sobel AT, Bokish VA, Müller-Eberhard HJ. C1q deviation test for the detection of immune complexes aggregates of IgG and bacterial products in human serum J Exp Med 1975; 142: 139-150.
14. Hasková V, Kaslik J, Riha I, Matl I, Rovensky J. Simple method of circulating immune complexes detection in human sera by polyethylene glycol precipitation. Z Immun-Forsch 1978; 154. 399-406
15. a ed. Ciudad de La Habana. Editorial Pueblo y Educación 1974; 111-118.
16. Cooper NR. The complement system. En: Stites Dp, Stobo JD, Wells JV (eds). Basic and Clinical Immunology, California, Lange Medical Publications 1987; 114-127.